🔗 Share this article

Chancellor Reeves has revealed she is planning "specific measures to deal with cost of living issues" in the upcoming financial statement.

In comments to the BBC, she emphasized that curbing inflation is a collective responsibility of both the administration and the central bank.

The UK's inflation rate is projected to be the most elevated among the G7 industrialized countries this year and next.

Potential Utility Bill Measures

Sources suggest the administration could intervene to lower utility costs, for instance by cutting the current 5% rate of value-added tax applied on energy supplies.

Another approach is to reduce some of the regulatory levies currently added to bills.

Budgetary Limitations and Analyst Expectations

The administration will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much room there is for these measures.

The expectation from the majority of experts is that the Chancellor will have to declare higher taxes or spending cuts in order to fulfill her self-imposed fiscal targets.

Previously on the same day, calculations suggested there was a £22bn gap for the Treasury chief to fill, which is at the lower end of forecasts.

"It is a collective responsibility between the central bank and the administration to bear down further on some of the causes of price increases," the Chancellor told the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Tax Pledges and Global Concerns

While a great deal of the focus has been on expected tax rises, the Treasury chief said the most recent figures from the OBR had not altered her vow to campaign commitments not to increase rates on income tax, sales tax or National Insurance.

She blamed an "uncertain global environment" with growing geopolitical and commercial concerns for the fiscal revenue measures, probably to be directed on those "with the broadest shoulders."

International Trade Disputes

Commenting on concerns about the UK's economic relations with the Asian nation she said: "Our security interests invariably come first."

Recent statement by China to strengthen trade restrictions on critical minerals and other resources that are key for high-technology production led American leader the US President to suggest an additional 100% import tax on imports from China, raising the prospect of an all-out commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "economic coercion" and "a global supply chain power grab."

Questioned on accepting the American proposal to participate in its conflict with the Asian nation, the Chancellor said she was "very concerned" by Chinese measures and called on the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "bad for the global economy and creates further obstacles."

"It is my opinion there are sectors where we need to challenge Chinese policies, but there are also significant opportunities to export to Chinese markets, including financial services and other areas of the economic system. We've got to achieve that equilibrium right."

The Treasury chief also affirmed she was cooperating with international partners "regarding our own essential resources strategy, so that we are more independent."

NHS Drug Pricing and Funding

The Chancellor also acknowledged that the price the NHS pays for drugs could go up as a result of ongoing negotiations with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.

Some of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or abandoning projects in the UK, with some attributing the insufficient payments they are receiving.

Last month, the Science Minister said the price the health service pays for drugs would need to increase to prevent companies and pharmaceutical investment departing from the United Kingdom.

The Chancellor told media: "We have seen because of the payment system, that medical research, recent pharmaceuticals have not been provided in the UK in the manner that they are in other EU nations."

"We want to guarantee that individuals getting care from the NHS are able to receive the top essential treatments in the globe. And so we are reviewing all of that, and... looking to attract more investment into the UK."